Image

Prognostic Value of Capillary Lactatemia in Potentially Severe Polytrauma Patients

Prognostic Value of Capillary Lactatemia in Potentially Severe Polytrauma Patients

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Nowadays, the tools available to assess the severity of a polytrauma patient in the pre-hospital setting (vital parameters, shock index, MGAP score, Vittel criteria) have their limitations and are sometimes subjective. To date, there are no objective, practical and reproducible tools for triaging these patients. Venous lactataemia also appears to be predictive of poor outcome in severe trauma. However, there are no studies in the literature on capillary lactataemia, which would indicate the potential severity of a polytrauma patient in the pre-hospital setting. However, it is an easily performed, risk-free assay, the results of which can be obtained rapidly at the scene of the accident. The aim of this project is to confirm that, like venous lactataemia, capillary lactataemia can be useful in the pre-hospital phase for predicting a patient's poor outcome. Incorporating this assay into the assessment of potentially severe polytrauma patients in the pre-hospital phase could improve the predictive value of clinical and contextual data and thus enable better referral and management of these patients.

Eligibility

Inclusion Criteria:

  • Patient over 18 years of age
  • Presenting a potentially serious pre-hospital trauma defined by:
    • A road accident or a fall of more than 2 metres
  • Requiring the dispatch of a SMUR 06 team (mobile emergency and resuscitation service)
  • And transferred to an emergency facility in the Alpes Maritimes with medical assistance.
  • Consent signed (by the patient or a relative) after the event if it is not possible to sign immediately.
  • Pregnant women may also take part in the study without any risk to themselves or their child.

Exclusion Criteria:

  • Patients with isolated peripheral limb trauma (wrist, elbow, knee, ankle, shoulder)
  • Patients under legal protection (guardianship, curatorship)
  • Patients in cardiorespiratory arrest when taken into care by the SMUR (emergency medical services)

Study details
    Polytrauma

NCT06969404

Centre Hospitalier Universitaire de Nice

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.